.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Mallinckrodt
Accenture
Chinese Patent Office
Merck
Julphar
McKesson
Colorcon
AstraZeneca

Generated: June 24, 2017

DrugPatentWatch Database Preview

FOSINOPRIL SODIUM Drug Profile

« Back to Dashboard

Which patents cover Fosinopril Sodium, and when can generic versions of Fosinopril Sodium launch?

Fosinopril Sodium is a drug marketed by Apotex Inc, Actavis Labs Fl Inc, Invagen Pharms, Watson Labs, Teva, Aurobindo Pharma Ltd, Prinston Inc, Ranbaxy Labs Ltd, Upsher-smith Labs, Mylan, Emcure Pharms India, Sun Pharm Inds Ltd, Aurobindo Pharma, and Sandoz. and is included in twenty NDAs.

The generic ingredient in FOSINOPRIL SODIUM is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.

Summary for Tradename: FOSINOPRIL SODIUM

Patents:0
Applicants:14
NDAs:20
Suppliers / Packagers: see list16
Bulk Api Vendors: see list57
Clinical Trials: see list2,350
Patent Applications: see list811
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FOSINOPRIL SODIUM at DailyMed

Pharmacology for Tradename: FOSINOPRIL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL090228-002Jul 9, 2009ABRXNoNo► Subscribe► Subscribe
Upsher-smith Labs
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL076188-002Oct 8, 2004DISCNNoNo► Subscribe► Subscribe
Teva
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076945-002Jul 5, 2006DISCNNoNo► Subscribe► Subscribe
Watson Labs
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077144-002Aug 16, 2005DISCNNoNo► Subscribe► Subscribe
Sandoz
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076961-001Sep 28, 2005ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Novartis
Express Scripts
Baxter
Chinese Patent Office
Queensland Health
Mallinckrodt
US Army
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot